- Home
- CLLS vs SMID Comparison
CLLS vs SMID Comparison
Compare CLLS & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SMID
- Stock Information
- Founded
- CLLS 1999
- SMID 1960
- Country
- CLLS France
- SMID United States
- Employees
- CLLS N/A
- SMID N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SMID Building Materials
- Sector
- CLLS Health Care
- SMID Industrials
- Exchange
- CLLS Nasdaq
- SMID Nasdaq
- Market Cap
- CLLS 143.4M
- SMID 157.4M
- IPO Year
- CLLS 2007
- SMID 1995
- Fundamental
- Price
- CLLS $1.59
- SMID $37.91
- Analyst Decision
- CLLS Buy
- SMID
- Analyst Count
- CLLS 1
- SMID 0
- Target Price
- CLLS $4.00
- SMID N/A
- AVG Volume (30 Days)
- CLLS 48.2K
- SMID 20.4K
- Earning Date
- CLLS 08-05-2025
- SMID 07-10-2025
- Dividend Yield
- CLLS N/A
- SMID N/A
- EPS Growth
- CLLS N/A
- SMID 444.88
- EPS
- CLLS N/A
- SMID 1.86
- Revenue
- CLLS $54,747,000.00
- SMID $84,450,000.00
- Revenue This Year
- CLLS $48.52
- SMID N/A
- Revenue Next Year
- CLLS $5.17
- SMID N/A
- P/E Ratio
- CLLS N/A
- SMID $19.14
- Revenue Growth
- CLLS 351.26
- SMID 33.01
- 52 Week Low
- CLLS $1.10
- SMID $25.13
- 52 Week High
- CLLS $2.43
- SMID $51.96
- Technical
- Relative Strength Index (RSI)
- CLLS 56.98
- SMID 71.21
- Support Level
- CLLS $1.56
- SMID $32.85
- Resistance Level
- CLLS $1.49
- SMID $35.37
- Average True Range (ATR)
- CLLS 0.09
- SMID 1.63
- MACD
- CLLS 0.01
- SMID 0.51
- Stochastic Oscillator
- CLLS 80.00
- SMID 82.07
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.